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ABSTRACT
Objectives: SGA is associated with higher incidence of postnatal complications, including suboptimal neurodevelopment 
and increased cardiovascular risk. Screening for SGA, carried out at 11–13 (+ 6d) gestational weeks enables to reduce or 
completely eliminate the above mentioned complications. The aim of this study was to assess the correlation between 
chorionic thickness, concentration of PIGF protein and foetal birth weight in a single low-risk pregnancy.
Material and methods: The study included 76 patients at 11–13 (+ 6d) gestational weeks, monitored throughout preg-
nancy. Ultrasound examinations identified the location and thickness of the chorion by measuring it in its central part at 
its widest point in a sagittal section. Additionally, at each visit venous blood was collected to determine the level of PlGF, 
PAPP-A, and BhCG.
Results: A significant positive correlation (r = 0.37) was found between the foetal weight and chorionic thickness. This 
correlation was affected by the location of the chorion and a significant negative correlation was observed between the 
level of PLGF, FHR, weight and length of the newborn. Maternal early-pregnancy BMI did not affect neonatal weight and 
body length, FHR, chorionic thickness, and the levels of PlGF, PAPP-A, and BhCG.
Conclusions: The preliminary analysis indicates an association between chorionic thickness assessed during ultrasound at 
11–13 (+ 6d) gestational weeks, PIGF levels assayed at the same time and birth weight. Increasing chorion thickness was 
accompanied by increasing foetal birth weight. PlGF level showed an inversely proportional effect on the foetal weight. 
This correlation was significant for the posterior location of the chorion.
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INTRODUCTION
The term ‘small for gestational age’ (SGA) has been 
coined to denote foetuses unable to reach normal body 
weight (defined as the 10th percentile in a growth chart) [1]. 
Although normal umbilical blood flow has been shown in 
SGA foetuses towards the end of pregnancy, the low birth 
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weight is associated with numerous postnatal complica-
tions. These include abnormal neuromotor development 
and increased cardiovascular risk, as compared to normal 
birth weight neonates [2].
Proper identification of pregnant women at risk of 
intrauterine hypotrophy enables increased pregnancy 
monitoring in selected cases, early treatment of potential 
maternal conditions, which increase the risk of abnormal 
foetal development, in order to reduce or eliminate the 
previously mentioned complications. The contemporary 
model of antenatal care aims at performing all risk assess-
ments, including the risk of complications, such as abnormal 
foetal development, during the first trimester. Plethora of 
research carried out in order to determine high sensitivity 
screening test for SGA is based on the findings of ultrasound 
assessment at 11–13 (+ 6d) gestational weeks and maternal 
serum biomarkers assayed at the same time.
The chorion, followed by the placenta at later stages 
of pregnancy, plays the key role in supplying the growing 
foetus with oxygen and nutrients, thus ensuring its normal 
development. Abnormal cytotrophoblast invasion (implan-
tation) leads to the decreased placental blood flow, which is 
one of secondary causes of abnormal foetal development. 
Size, shape and maturity of the placenta strongly correlate 
with the birth weight [3–6]. Currently, the only standard 
element of ultrasound-based assessment of the chorion 
(placenta) includes determining its location relative to the 
internal cervical os [3–6]. In recent years, though, studies 
have been published, which suggest correlation between 
chorionic volume and intrauterine hypotrophy. 
Until recently, the narrow laboratory test panel for the 
first trimester included maternal serum PAPP-A and BhCG 
assays only. Nowadays, though, the research has focused on 
extending it by additional biomarkers, such as P13, PTX-3 , 
sFLT-1,VEGF-1, sP-selectin and fibronectin, which may help 
assess the risk of developing an individual clinical condition 
later in pregnancy. In recent years, some attention has been 
paid to the placental growth factor (PIGF), which is one of 
the vascular endothelial growth factors (VEGF). Produced 
by trophoblast cells, PIGF is essential for normal placental 
development. Low serum free PlGF levels were seen in the 
first and second trimester of pregnancy in women present-
ing subsequently with preeclampsia [7–10]. Low urinary 
PlGF levels were seen at 25–28 gestational weeks in women 
presenting subsequently with late-onset preeclampsia. Fur-
thermore, its predictive value in Down Syndrome and other 
chromosomal disorders has been established [11].
OBJECTIVES
The aim of the research was to determine the association 
between chorionic thickness, PIGF levels and ultimate birth 
weight in a single low-risk pregnancy.
MATERIAL AND METHODS
The study included 76 patients of the Antenatal Clinic 
of the Podhalański Specialist Hospital in Nowy Targ. Their 
gestational age on enrolment was 11 to 13 (+ 6d) weeks.
All patients were informed about the purpose and scope 
of the research, and gave their informed consent to par-
ticipate.
The mean patient age was 28.3 years. The cohort con-
sisted of 34 primigravida and 42 multigravida. The mean ma-
ternal BMI was 24.4 (kg/m2). Comorbidities were present in 
three females: one case of factor V Leiden thrombophilia, 
hyperlipidaemia and polycystic kidney disease, respectively. 
All analysed pregnancies ended in term live birth (at or after 
37 gestational weeks) with caesarean section performed in 
18 cases, as compared to 57 cases of vaginal delivery. The 
lowest birth weight was 1900 g (at 37 gestational weeks) 
and the highest birth weight was 4600 g (at 41 gestational 
weeks). The standard ultrasound assessment at 11–13 (+ 6d) 
gestational weeks demonstrated the location of the chorion 
on the anterior uterine wall in 44 cases and on the posterior 
uterine wall in 32 cases (Tab. 1).
Survey-based history was taken from all enrolled pa-
tients. It included such data as:
 Ū maternal age, 
 Ū maternal education level,
 Ū gravidity and parity, 
 Ū comorbidities,
 Ū complications in previous pregnancies *(in multi-
gravida only),
 Ū smoking status, 
 Ū use of contraception before pregnancy
 Ū barrier, vs. hormone.
The antenatal ultrasound performed at 11–13 (+ 6d) 
gestational weeks aimed at assessing the following:
 Ū foetal anatomy and chromosomal aberration bio-
markers, in line with assessment standards set out 
by the Ultrasound Section of the Polish Society of 
Gynaecology (foetal biometry: CRL, BPD, and chro-
mosomal aberration biomarkers: NT, NB, DV),
 Ū uterine artery blood flow,
 Ū chorionic thickness, measured centrally at the wid-
est point in sagittal view, perpendicularly to chori-
onic-uterine interface.
During the study visit, a blood sample was collected 
in each patient for the following tests: PAPP-A, B-hCG and 
PlGF. The collected venous blood samples were maintained 
at room temperature for 30–40 minutes, until clotted. The 
serum was separated within 24 hours following sample 
collection. The preprocessed blood samples were frozen at 
–20oC. Next, the samples were transported under storage 
conditions determined by DHL, by special courier deliv-
ery to the Central Laboratory, Gynaecology and Obstetrics 
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University Hospital of K. Marcinkowski Poznań University 
of Medical Sciences, where PIGF, PAPP-A and BhCG levels 
were determined in ISO9000-certified laboratory facilities.
The PlGF level was determined using the immuno-
fluorometric assay on DELFIA Xpress analyser. The method 
involves coating the surface of the reaction cup with the 
specific IgG capture antibody targeting the respective 
determinant of the PIGF molecule present in the serum. 
The labelled non-specific, detection antibody is applied to 
target another determinant of the molecule. It is followed 
by the 20-minute incubation at +35o, when the antibodies 
bind to their target determinants. Next, the reaction cup 
is washed in order to remove excess unbound antibodies, 
so that the reaction mix contains only analyte antibody 
complexes. Subsequently, an inducer is added to the mix. It 
releases the label from the ‘sandwich’ complex and induces 
its fluorescence. The fluorescence is measured at 612 nm, 
and its intensity is directly proportional to the PIGF level. 
PAPP-A — Pregnancy Associated Placental Protein is 
a metalloproteinase derivative synthesized in the syncy-
tiotrophoblast, which cleaves the IGF-binding proteins 
and ensures appropriate trophoblast implantation [12]. 
The PAPP-A levels were determined using immunofluo-
rometric assay on DELFIA Xpress analyzer, which involves 
coating the surface of the reaction cup with the specific 
IgG capture antibody targeting the respective determinant 
of the PAPP-A/proMBP complex present in the serum. The 
Europium-labelled non-specific, detection antibody is ap-
plied to target another determinant of the molecule. It is 
followed by the 20-minute incubation at +35o, when the 
antibodies bind to their target determinants. Next, the re-
action cup is washed in order to remove excess unbound 
antibodies, so that the reaction mix contains only analyte 
antibody complexes. Subsequently, an inducer is added to 
the mix. It releases the label from the ‘sandwich’ complex 
and induces its fluorescence. The fluorescence is measured 
at 612 nm, and its intensity is directly proportional to the 
PAPP-A level. 
Human chorionic gonadotropin (hCG) is a glycoprotein 
hormone (molecular weight of ~37 kDa) consisting of two 
noncovalently bound dissimilar subunits, designated α 
and β (molecular weight of ~15 and 22 kDa, respectively). 
HCG is secreted by trophoblast cells in the placenta and its 
role involves maintaining the corpus luteum over the early 
weeks of pregnancy. Additionally, it is known to regulate 
steroid production [13, 14]. The β-hCG assay, measuring the 
level of its free β subunit, is a multi-step process. The first 
stage involves incubation. The 10 μL sandwich complex 
sample contains biotinylated, monoclonal βhCG-specific 
antibody and a ruthenylated, βhCG-specific antibody. After 
Table 1. Characteristics of the research material
Maternal age [years] mean ± SD (min-max) 28.3 + 4.9 (19–41)
Maternal body weight [kg] mean ± SD (min-max) 65.7 + 12.6 (44.6–99)
Maternal body height [cm] mean ± SD (min-max) 164.5 + 6.1 (150–176)
Maternal body mass index [kg/m2] mean ± SD (min-max) 24.4 + 4.8 (17.6–39)
BMI-based nutritional status assessment
Underweight n (%) 6 (7.9%)
Normal n (%) 42 (55.3%)
Overweight n (%) 15 (19.7%)
Obese n (%) 13 (17.1%)
Pregnancy duration — mean ± SD (min-max) 39.3 + 1.2 (37–41)
Delivery method
Caesarean section n (%) 18 (24%)
Vaginal delivery n (%) 58 (76%)
Birth weight [g] mean ± SD (min-max) 3342 ± 454 (1900–4600)
Birth length [g] mean ± SD (min-max) 55 ± 2 (47–61)
Number of pregnancies
Primigravida n (%) 34 (44.7%)
Multigravida n (%) 42 (55.3%)
Use of contraceptives
No n (%) 70 (92.1%)
Hormone n (%) 5 (6.6%)
Barrier n (%) 1 (1.3%)
Location of the chorion
Anterior wall n (%) 44 (57.9%)
Posterior wall n (%) 32 (42.1%)
90
Ginekologia Polska 2017, vol. 88, no. 2
www. journals.viamedica.pl/ginekologia_polska
streptavidin coated microparticles are applied, the com-
plex binds to the solid phase via biotin — streptavidin 
affinity-mediated interactions. The reaction mix is then 
transferred to a measuring cell, where the microparti-
cles are magnetically captured onto the surface of the 
electrode. The unbound particles are removed using the 
ProCell/ProCell M washing reagents. Afterwards, the elec-
trochemiluminescence reaction and photon emission are 
induced by applying a voltage to the electrode and meas-
ured using the photomultiplier. The results are determined 
via a calibration curve which is instrument-specifically 
generated by a 2-point calibration and a master curve 
provided via the reagent barcode.
Statistical analysis included univariate and bivariate 
ANOVA as well as Pearson linear correlation. The p val-
ue ≤ 0.05 was considered statistically significant. Distri-
bution normality for all analysed parameters in the entire 
cohort and the identified subgroups was assessed using 
the Shapiro-Wilk test.
RESULTS
The correlation analysis revealed a significant positive 
correlation (r = 0.37) between the birth weight and chorionic 
thickness in the first trimester in the entire cohort. Similarly, 
a statistically significant correlation (r = 0.42) was demon-
strated in the arm with the chorion located on the anterior 
uterine wall. In the arm with the chorion located on the pos-
terior uterine wall, a statistically insignificant trend towards 
the positive correlation (r = 0.33, p = 0.06) between chorionic 
thickness and ultimate birth weight was noticed. However, 
a statistically significant positive correlation (r = 0.35) be-
tween the birth length and chorionic thickness in the first 
trimester was demonstrated in this arm (Tab. 2, Fig. 1).
A statistically significant negative correlation was dem-
onstrated in the study cohort between the maternal serum 
PIGF levels, foetal heart rate (FHR), birth weight and length, 
which was not confirmed in the arm with the chorion lo-
cated on the anterior uterine wall. In the arm with the loca-
tion of chorion at the posterior uterine wall, a statistically 
Table 2.The correlation between the level of proteins in maternal serum, chorionic thickness in the first trimester, foetal heart rate in the first 
trimester and the ultimate birth parameters
Group  Chorionic thickness [mm] PIGF [mU/L] PAPP-A [mU/L] BhCG [ng/mL]
Total
FHR [min]
r = 0.0632 r = –0.4577 r = –0.2158 r = 0.2833
n = 76 n = 65 n = 75 n = 75
p = 0.587 p = 0.000 p = 0.063 p = 0.014
Birth weight [g]
r = 0.3687 r = –0.2641 r= –0.1493 r = –0.0195
n = 76 n = 65 n = 75 n = 75
p =0.001 p = 0.034 p = 0.201 p = 0.868
Birth lenght [cm]
r = 0.2199 r = –0.2683 r= –0.0378 r = 0.0918
n = 76 n = 65 n = 75 n = 75
p = 0.056 p = 0.031 p = 0.748 p = 0.434
r — Pearson linear correlation coefficient; n — number of cases; p — statistical significance level
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Figure 1. The correlations between chorionic thickness, measured at 11–13 (+ 6d) gestational weeks and ultimate birth parameters
91
Anna Gąsiorowska et al., Chorionic thickness and PlGF concentrations
www. journals.viamedica.pl/ginekologia_polska
Figure 3.The correlations between ultimate birth parameters and the level of PlGF determined in maternal serum during the first trimester of 
pregnancy
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Figure 2. The correlations between FHR measured at 11–13 (+ 6d) 
gestational weeks and the level of PlGF determined in maternal 
serum during the first trimester of pregnancy
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Table 3. The analysis of average chorionic thickness measured at 11–13 (+ 6d) gestational weeks in 3 classes of birth weight
Group Birth weight n
Chorionic thickness [mm]
ANOVA
Mean SD Me Min Max
Total
1900–3000 20 18.93 5.19 18.15 12.2 35.9
p < 0.001
3100–3590 35 23.23 8.2 21.7 12.2 48
3600–4600 21 29.13 7.86 28.6 18.6 47.3
Location of the 
chorion on the 
anterior uterine wall
1900–3000 13 17.22 3.33 16.8 12.2 22.5
p = 0.001
3100–3590 18 23.42 7.67 21.55 13.9 44.6
3600–4600 13 27.29 7.49 23.4 18.6 44
Location of the 
chorion on the 
posterior uterine wall
1900–3000 7 22.11 6.7 20.1 16.3 35.9
p = 0.033
3100–3590 17 23.02 8.95 21.7 12.2 48
3600–4600 8 32.13 7.99 30.85 22.9 47.3
significant, negative correlation was demonstrated between 
PIGF levels and FHR, birth weight and length, as well as 
between PAPP-A levels and FHR.
Furthermore, a statistically significant positive correla-
tion was perceived between BhCG levels and FHR, in the 
entire cohort and in its arm with location of the chorion on 
the posterior uterine wall (Fig. 2, Fig. 3). 
Finally, the maternal body mass index (BMI) at the begin-
ning of pregnancy was shown not to affect the birth weight 
and length, FHR, chorionic thickness and maternal serum 
PIGF, PAPP-A and BhCG levels.
Then, the cohort was divided into 3 groups, by birth 
weight assessed using the growth chart. Subgroup I includ-
ed newborns with birth weight below the 25th percentile, 
group II included newborns with birth weight between 
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The analysis of variance did not demonstrate a signifi-
cant correlation between chorionic thickness, PIGF levels 
and birth weight (Tab. 4, Fig. 5). However, as shown in 
Figure 8 the birth weight to PIGF level variance between 
subgroups with low (below 25th percentile) and medium 
(25–75th percentile) PIGF levels tended to follow the trend 
previously seen in groups with low, medium and large 
chorionic thickness. The lowest birth weight was shown in 
subgroups where low and medium PIGF levels coexisted 
with low chorionic thickness. In cases with medium chori-
onic thickness (27–75th percentile), the birth weight slightly 
increased in both subgroups, whereas in cases with large 
chorionic thickness, the birth weight did not virtually differ 
between the subgroups of low and medium PIGF levels. In 
a subgroup with high PIGF levels (> 75th percentile), though, 
the birth weight variance followed a completely different 
pattern. When chorionic thickness was analysed as a pre-
dictor variable, the mean birth weight in subjects with low 
chorionic thickness and high PIGF levels was 2960 g, increas-
ing to 3137 g in subjects with medium chorionic thickness 
and high PIGF levels. However, the highest birth weight 
was seen in subjects with consistently high values of both 
chorionic thickness and PIGF level. This association may 
prove significant when tested in a bigger sample.
The mean birth weight in a subgroup with low chorionic 
thickness (below 25th percentile) was only 2988 g. It in-
creased significantly to 3379 g in the subgroup with medium 
chorionic thickness (25–75th percentile) to reach 3523 g 
in the group with large chorionic thickness (above 75th 
percentile). The observed effect was statistically significant 
(p = 0.0026). While the difference in birth weight between 
the subgroups with low and medium chorionic thickness 
was significant and amounted to 391 g, there was only slight 
birth weight increase of 144g between the subgroups with 
medium and large chorionic thickness (Tab. 5, Fig. 6).
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Figure 4. The average chorionic thickness measured at 11–13 (+ 6d) 
gestational weeks in 3 classes of birth weight
Table 4. The average level of PlGF determined in the first trimester of pregnancy in 3 groups of birth weight
Group Birth weight n
PIGF [mU/L]
ANOVA
Mean SD Me Min Max
PlGF [mU/L]
1900–3000 16 41.62 22.59 33.65 15.9 90.8
NS3100–3590 29 30.71 12.02 26.6 13.6 59.4
3600–4600 20 33.89 8.84 32.15 17.4 53.1
PlGF [mU/L]
1900–3000 11 35.62 17.45 29.2 15.9 73.2
NS3100–3590 16 28.93 11.83 24.9 13.6 59.4
3600–4600 12 34.78 8.28 32.15 24.9 53.1
PlGF [mU/L]
1900–3000 5 54.84 28.9 59.18 23.6 90.8
p = 0.0363100–3590 13 32.91 12.36 29.5 16.2 52.8
3600–4600 8 32.55 10.06 33.9 17.4 46.2
the 25th and 75th percentile, whereas group III included 
newborns with birth weight above the 75th percentile. The 
univariate analysis of variance (ANOVA) was used to com-
pare chorionic thickness measured during the ultrasound 
assessment at 11–13 (+ 6d) gestational weeks between the 
three subgroups. A significant correlation between birth 
weight and chorionic thickness was demonstrated for the 
three subgroups, measured for both the entire cohort, and 
its respective arms with location of the chorion on the an-
terior or posterior uterine wall. The increase of chorionic 
thickness with the ultimate birth weight was consistently 
seen in all subgroups (Tab. 3, Fig. 4). 
The results obtained using the univariate ANOVA were 
replicated in subsequent bivariate analysis of birth weight 
variance, which showed statistically significant association 
between birth weight and chorionic thickness (p = 0.003) 
and a non-significant association between birth weight and 
PIGF levels (p = 0.045).
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The mean birth weight in the subgroup with low PIGF 
level (below 25th percentile) was 3275 g. It increased slightly 
to 3471 g in the subgroup with medium PIGF levels (25–
75th percentile), but in cases with large chorionic thickness 
(above 75th percentile) it dropped to only 3142 g, below 
the level seen in the subgroup with low PIGF levels. The 
observed effect was trending towards statistical significance 
(Tab. 6, 7 Fig. 7).
DISCUSSION
Our research focused on clinical utility of structural 
(thickness) and functional (PIGF) placental parameters as 
low birth weight predictors. 
Table 5. Mean birth weight calculated for intervals adopted for 
chorionic thickness measured at 11–13 (+ 6d) gestational weeks
Chorionic 
thickness 
[mm]
Birth weight [g]
N
Mean Standard error
95% confidence 
interval
12.2–18.5 2988 104.20 2779 3196 17
18.6–26.9 3379 81.14 3216 3542 29
27.0–48.0 3523 121.25 3280 3765 19
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Figure 5. The average level of PlGF determined in the first trimester of 
pregnancy in 3 groups of birth weight Figure 6. The birth weight and chorionic thickness in 3 groups 
— below 25th, 25–75th, and above 75th percentile
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Table 6. The mean birth weight calculated for the adopted ranges 
of PIGF level determined in the first trimester of pregnancy
PIGF 
[mU/L]
Birth weight [g]
N
Mean Standard error
95% confidence 
interval
13.6–23.3 3275 122.07 3031 3520 17
23.4–40.5 3471 79.90 3311 3632 31
40.6–90.8 3142 104.20 2934 3351 17
Figure 7. The birth weight and PLGF level in 3 groups — below 25th, 
25–75th, and above 75th percentile
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Figure 8. The birth weight and the interaction between chorionic 
thickness and PIGF level
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Our findings indicate the relationship between PlGF 
levels, chorionic thickness and ultimate birth weight. The 
location of the chorion on the anterior vs. the posterior 
uterine wall appears to significantly affect the discussed 
correlation. In the arm with the location of chorion at the 
posterior uterine wall, a statistically significant, negative 
correlation was demonstrated between PIGF levels and 
FHR, birth weight and length. Furthermore, the location of 
chorion affects the correlation between PAPP-A levels and 
FHR, which was statistically significant and negative in the 
arm with the location of chorion at the posterior uterine 
wall. This correlation was not confirmed in the arm with 
the location of chorion on the anterior uterine wall or in 
the entire cohort. 
Additionally, we demonstrated high PlGF levels in moth-
ers of low birth weight newborns. A positive correlation was 
shown between the birth weight and chorionic thickness 
assessed with the 2D ultrasound at 11–13 (+ 6d) gesta-
tional weeks. The effect of maternal age and BMI on the 
birth weight was not statistically significant. However, it 
should be noted that our cohort consisted of females with 
normal body mass index, which additionally emphasizes 
the obstetric uniqueness of obese women, in whom the as-
sociation between maternal BMI and the risk of intrauterine 
hypertrophy was confirmed. 
The literature review for the research of SGA reveals 
that finding the optimum diagnostic algorithm based on 
thorough medical history, ultrasound findings from the first 
trimester and maternal serum protein levels has been the 
main focus of recent studies. Such diagnostic algorithm is 
intended to serve as screening for SGA and IUGR.
The SGA prediction model proposed by Schwarz et al. is 
based on serum PIGF and PP13 levels as well as chorionic as-
Table 7. The mean birth weight calculated for the adopted intervals of PIGF level, determined in the first trimester of pregnancy, and chorionic 
thickness measured at 11–13 (+ 6d) gestational weeks
Chorionic thickness 
[mm] PIGF [mU/L]
Birth weight [g]
N
Mean Standard error 95% confidence interval
12.2–18.5
13.6–23.3 3031 157.96 2715 3348 7
23.4–40.5 3242 170.61 2.900 3583 6
40.6–90.8 2690 208.96 2271 3109 4
18.6–26.9
13.6–23.3 3420 147.76 3124 3716 8
23.4–40.5 3580 111.69 3356 3804 14
40.6–90.8 3137 157.96 2821 3454 7
27.0–48.0
13.6–23.3 3375 295.51 2783 3967 2
23.4–40.5 3593 126.01 3340 3845 11
40.6–90.8 3600 170.61 3258 3942 6
sessment in 3D ultrasound in the first trimester. They found 
that patients with SGA had significantly lower PIGF levels 
(p = 0.02). Additionally, they demonstrated that patient age, 
BMI and nulliparity did not affect SGA. However, according 
to their analyses, there was a statistically significant associa-
tion between such factors as non-white race, concomitant 
chronic hypertension or smoking and SGA. The chorion 
was assessed using 3D ultrasound (VOCAL). It was asserted 
that all chorionic thickness values in SGA were significantly 
lower as compared to those in normal birth weight new-
borns and that the flatter chorions of larger surface area 
were associated with foetal growth abnormalities. Finally, 
they concluded that the 2D ultrasound-based chorionic 
assessment had a similar predictive value to the one of 3D 
ultrasound-based one, while being much easier and quicker 
to perform [15]. Other researchers developed the so-called 
placental profile, which combines two chorionic dimensions 
(i.e. its length and thickness). Along with serum biomarkers, 
it offered an excellent predictive value [16–20]. However, as 
the study was done in extremely high-risk pregnancy cases, 
high rates of unfavourable outcomes were reported. 
In 2015, a paper was published that compared the 2D 
and 3D ultrasound-based assessment of chorionic volume, 
as a part of larger SGA screening in the first trimester. The 
study was conducted in 139 patients. It demonstrated low 
compliance of both methods, which was attributed to heter-
ogeneous chorionic structure at this stage of pregnancy [21].
The effect of chorionic thickness on the ultimate birth 
weight was also assessed in the second trimester, with a 3D 
ultrasound performed at 17–20 gestational weeks [22]. The 
placental volume was shown to be significantly lower in 
SGA group as compared to the average birth weight group 
(p = 0.015).
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CONCLUSIONS
The preliminary analysis of presented data indicates an as-
sociation between chorionic thickness assessed during the 
antenatal ultrasound at 11–13 (+ 6d) gestational weeks, PIGF 
levels assayed at the same time and birth weight. Chorionic 
thickness significantly affects birth weight. The ultimate birth 
weight increases with chorionic thickness. An inverse correla-
tion was demonstrated between PIGF level and birth weight. 
It was statistically significant only in patients with chorion 
located on the posterior uterine wall. Chorion location on 
the posterior uterine wall affects both the inverse correlation 
between PAPP-A and birth weight, as well as the positive 
correlation between BhCG levels and birth weight. Change in 
chorionic thickness from 12.2 to 26.9 mm significantly affects 
the ultimate birth weight. However, its further increase over 
27 mm does not have a significant effect on birth weight. In 
terms of PIGF levels, the highest birth weight was seen in cases 
with PIGF level ranging between 23.4 and 40.5uU/L and it was 
lower in cases with PIGF levels below or above this range.
The birth weight in cases with PIGF levels ranging 
between 40.5 and 90.8 uU/L can be expected to increase 
linearly with chorionic thickness. On the other hand, no 
interaction effect was demonstrated between PIGF level 
and chorionic thickness in cases with low or medium PIGF 
levels. Nevertheless, it should be emphasized that our re-
sults were obtained from a small cohort study. Therefore, it 
appears legitimate to design a prospective observational 
study in a larger cohort, in order to replicate our results and 
further specify PIGF ranges. 
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